Abstract
Abstract. Due to physical limitations (e. g. difficulties in reading and writing), geriatric inpatients are often not able to complete relevant dementia screening tests. The Bamberg Dementia Screening Test (BDST) is a new dementia screening measure that can be administered in a few minutes as “true bedside” – test. 150 patients suffering from mild cognitive impairment (MCI) and mild or moderate dementia as well as a control sample of 40 cognitively unimpaired participants completed the BDST and the CERAD-Plus test battery. High correlations of BDST-subscores with CERAD subtests of corresponding content and between the total scores of the two tests could be found. Using the BDST, mild dementia and MCI patients could be discriminated from healthy controls with high sensitivity and specificity.
Zusammenfassung. Patienten geriatrischer Stationen sind, da sie z. B. aufgrund ihrer körperlichen Einschränkungen schlecht zeichnen, lesen oder schreiben können, oft nicht in der Lage, klassische Demenzscreenings zu bearbeiten. Beim Bamberger Demenz Screening Test (BDST) handelt es sich um ein neu entwickeltes Screeningverfahren, das in wenigen Minuten als Bedside-Test durchführbar ist. 150 Patienten mit leichter kognitiver Störung (MCI), leichter und mittelschwerer Demenz sowie einer Kontrollgruppe von 40 unbeeinträchtigten Personen wurden der BDST und die CERAD-Plus Testbatterie vorgegeben. Es finden sich hohe Korrelationen der BDST-Subscores mit den inhaltlich entsprechenden CERAD Subtests sowie zwischen den Gesamtscores der beiden Verfahren. Mittels des BDST konnte zudem mit hoher Sensitivität und Spezifität zwischen gesunden Personen, Personen mit leichter kognitiver Störung (MCI) und Personen mit dementiellem Syndrom differenziert werden.
References
2012). Best practice guidelines: optimal preoperative assessment of the geriatric surgical patient. http://www.americangeriatrics.org/health_care_professionals/clinical_practice/clinical_guide lines_recommendations
(2002). Validierung der Neuropsychologischen Testbatterie CERAD-NP: Eine Multi-Center Studie. PhD thesis, Basel, University of Basel.
(2009). Clinical and cost effectiveness of services for early diagnosis and intervention in dementia. International Journal of Geriatric Psychiatry, 24, 748 – 754.
(2000). The Mini-Cog: a cognitive ‘vital signs’ measure for dementia screening in multi-lingual elderly. International Journal of Geriatric Psychiatry, 15, 1021 – 1027.
(2003). Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force. Annals of Internal Medicine, 138, 927 – 937.
(2005). Delirious about Dementia: Towards better services for patients with cognitive impairment by geriatricians. London: Author.
(2004). Characteristics of the GPCOG, a screening tool for cognitive impairment. International Journal of Geriatric Psychiatry, 19, 870 – 874.
(2007). A review of screening tests for cognitive impairment. Journal of Neurology, Neurosurgery and Psychiatry, 78, 790 – 799.
(2009). S3-Leitlinie “Demenzen”. Bonn: Autor.
. (2000). The FAB. A frontal assessment battery at bedside. Neurology, 55, 1621 – 1626.
(2005). Global prevalence of dementia: a Delphi consensus study. Lancet, 366, 2112 – 2117.
(1975). “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189 – 198.
(2012). An economic evaluation of early assessment for Alzheimer’s disease in the United Kingdom. Alzheimer Dementia, 8, 22 – 30.
(2008). Parkinson’s disease dementia: definitions, guidelines, and research perspectives in diagnosis. Annals of Neurology, 64(Suppl 2), 81 – 92.
(2001). Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Disease and Associated Disorders, 15, 169 – 173.
(2004). CERAD-NP und flexible battery approach. Zeitschrift für Gerontopsychologie & -psychiatrie, 17, 77 – 95.
(2004). DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. International Journal of Geriatric Psychiatry, 19, 136 – 143.
(2005). Cognitive assessment for clinicians. Journal of Neurology, Neurosurgery and Psychiatry, 76(Suppl 1), 22 – 30.
(2000). Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology, 54, 1050 – 1058.
(1984). Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology, 34, 939 – 944.
(2005). Cognitive impairment is the major risk factor for development of geriatric syndromes during hospitalization: results from the GIFA study. Dementia and Geriatric Cognitive Disorders, 20, 262 – 269.
(2012). The Mini-Cog versus the Mini-Mental State Examination and the Clock Drawing Test in daily clinical practice: screening value in a German Memory Clinic. International Psychogeriatrics, 24, 766 – 774.
(2009). A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment. Journal of Psychiatric Research, 43, 411 – 431.
(2005). The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53, 695 – 699.
(2006). Dementia: supporting people with dementia and their carers in health and social care. NICE Clinical Guidance 42. London, UK: Author.
(1998). Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology, 51, 1546 – 1554.
(1996). Comparison of neuropsychological functioning in Alzheimer’s disease and frontotemporal dementia. Journal of the International Neuropsychological Society, 2, 505 – 510.
(2006). Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI working group of the European consortium on Alzheimer’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 77, 714 – 718.
(1999). Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology, 43, 250 – 260.
(2009). Dementia in the acute hospital: prospective cohort study of prevalence and mortality. British Journal of Psychiatry, 195, 61 – 66.
(2014). Cerebrospinal fluid apolipoprotein E concentration and severity of cognitive impairment in patients with newly diagnosed Alzheimer’s disease. American Journal of Alzheimer’s Disease and other Dementias, 29, 54 – 60.
(1986). Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clinical Gerontology, 5, 165 – 173.
(2005). Should we screen for Alzheimer’s disease? A review of the evidence for and against screening Alzheimer’s disease in primary care practice. Geriatrics, 60, 26 – 31.
(2000). Ten-year follow-up survey of clinical neuropsychologists: part I. Practices and beliefs. The Clinical Neuropsychologist, 14, 18 – 37.
(2006). The TCN/AACN 2005 “salary survey”: professional practices, beliefs, and incomes of U.S. neuropsychologists. The Clinical Neuropsychologist, 20, 325 – 364.
(2011). The TCN/AACN 2010 “salary survey”: professional practices, beliefs, and incomes of U.S. neuropsychologists. The Clinical Neuropsychologist, 25, 12 – 61.
(